In vitro activities of five new antimicrobial agents against Brucella melitensis.
Trujillano-Martín
I
I
García-Sánchez
E
E
Fresnadillo
M J
MJ
García-Sánchez
J E
JE
García-Rodríguez
J A
JA
Montes Martínez
I
I
D000081:Acetamides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017347:Brucella melitensis / Q000187:drug effects*; D006801:Humans; D000069349:Linezolid; D008826:Microbial Sensitivity Tests; D016712:Mupirocin / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D023303:Oxazolidinones; D017828:Rifabutin / Q000494:pharmacology; D014769:Virginiamycin / Q000031:analogs & derivatives / Q000494:pharmacology
D000081:Acetamides; D000900:Anti-Bacterial Agents; D010080:Oxazoles; D023303:Oxazolidinones; D014769:Virginiamycin; D017828:Rifabutin; C113825:quinupristin; C098011:eperezolid; D016712:Mupirocin; D000069349:Linezolid